Evidence map›Paper›PMID 39673524›Full record

ArticleNucleic acids research2025

CRISPR-based dissection of miRNA binding sites using isogenic cell lines is hampered by pervasive noise.

Mahendra K Prajapat, Andrea G Maria, Joana A Vidigal

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. MicroRNA Gets a Mighty Award.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Mahendra K PrajapatLaboratory of Biochemistry and Molecular Biology, National Cancer Institute, The National Institutes of Health, 37 Convent Dr, Bethesda, MD 20892, USA.ORCID 0000-0002-8090-6552
Andrea G MariaLaboratory of Biochemistry and Molecular Biology, National Cancer Institute, The National Institutes of Health, 37 Convent Dr, Bethesda, MD 20892, USA.
Joana A VidigalLaboratory of Biochemistry and Molecular Biology, National Cancer Institute, The National Institutes of Health, 37 Convent Dr, Bethesda, MD 20892, USA.ORCID 0000-0002-1660-615X

Funding

Canonical and non-canonical roles of Argonaute proteins in mammalsZIABC011810 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI VIDIGAL, JOANA · 2018 to 2025
$7.6M
CCR NIH HHSIntramural NIH HHS ZIA BC011810NIH HHS 1ZIABC011810-02
6 · The paper itself

Abstract

Non-coding regulatory sequences play essential roles in adjusting gene output to cellular needs and are thus critical to animal development and health. Numerous such sequences have been identified in mammalian genomes ranging from transcription factors binding motifs to recognition sites for RNA-binding proteins and non-coding RNAs. The advent of CRISPR has raised the possibility of assigning functionality to individual endogenous regulatory sites by facilitating the generation of isogenic cell lines that differ by a defined set of genetic modifications. Here we investigate the usefulness of this approach to assign function to individual miRNA binding sites. We find that the process of generating isogenic pairs of mammalian cell lines with CRISPR-mediated mutations introduces extensive molecular and phenotypic variability between biological replicates confounding attempts at assigning function to the binding site. Our work highlights an important consideration when employing CRISPR editing to characterize non-coding regulatory sequences in cell lines and calls for the development and adoption of alternative strategies to address this question in the future.

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsGene EditingMicroRNAsAnimalsBinding SitesCell LineHEK293 CellsHumansMutationMicroRNAs

Identifiers

PMID39673524
PMCPMC11724307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.